Aging is notoriously associated with a decline in immune function, leading to increased susceptibility to infectious diseases and diminished vaccine efficacy among older adults. Zhang’s research aims to decode the molecular underpinnings of this deterioration, focusing on the epigenetic regulation of T cell aging, specifically the role of a protein called HELIOS in helper T cells—a critical subset of immune cells orchestrating the body’s antibody production. Her laboratory hypothesizes that age-related loss of HELIOS disrupts the functional crosstalk between helper T cells and B cells, weakening humoral immunity.

Helper T cells, often described as the immune system’s “coaches,” are essential in guiding B cells to produce high-affinity antibodies that neutralize pathogens. Zhang’s work has revealed that the decline of HELIOS in these cells is central to the loss of this guiding function. This protein acts as an epigenetic regulator, influencing gene expression patterns that determine T cell differentiation and function. The gradual depletion of HELIOS with age results in compromised T follicular helper (TFH) cell activity, thereby impairing the body’s ability to mount robust antibody responses.

The innovative aspect of Zhang’s project lies in investigating whether restoring HELIOS expression in aged T cells can rejuvenate their function. By deploying cutting-edge molecular biology techniques and epigenomic profiling, her lab is exploring the possibility of reprogramming aged immune cells to regain youthful functionality. If successful, this approach could revolutionize vaccine development by creating strategies that bolster immune responsiveness, especially in populations that typically exhibit poor vaccine outcomes.

One of the technical focal points of Zhang’s research is the mechanistic understanding of HELIOS as a transcription factor modulating chromatin accessibility and gene transcription in aging T cells. Utilizing single-cell RNA sequencing and chromatin immunoprecipitation assays, her team aims to map the epigenetic landscape changes accompanying T cell senescence. These methodologies offer unprecedented resolution into how aging remodels immune cell function at a molecular scale.

Moreover, by delineating the pathways governing HELIOS expression and its regulatory network, Zhang’s research could identify novel molecular targets for immunotherapeutic interventions. The potential to develop small molecules or biologics that mimic or enhance HELIOS function may open new horizons for therapies designed to reinvigorate the aged immune system. This could lead to reduced morbidity and mortality from infections such as influenza, pneumonia, and shingles among the elderly.

Zhang’s research also underscores a paradigm shift in the conceptualization of aging immunity—not as irrevocably broken but as malleable and reprogrammable. This perspective fuels a proactive approach to medicine, focusing on restoring immune vigor rather than merely managing age-associated diseases. By leveraging molecular reprogramming, therapies may enable older adults to maintain disease resistance akin to younger individuals, substantially improving healthspan.

The potential societal impact of these findings is vast. Strengthening immune defenses in the aging population can dramatically reduce hospitalization rates and healthcare costs associated with infectious diseases in seniors. Enhancing vaccine efficacy through molecular adjuncts targeting HELIOS pathways could redefine public health strategies, particularly in the wake of pandemics where vulnerable groups suffer disproportionate mortality.

Beyond its therapeutic implications, Zhang’s work contributes to the fundamental understanding of immunosenescence—the gradual deterioration of the immune system with age—and the epigenetic factors steering it. Such knowledge enriches the broader scientific discourse on aging biology and promotes the integration of immunology and epigenetics to form more comprehensive models of age-related decline.

Zhang’s academic pedigree, including a doctorate in biochemistry and molecular biology from UCLA and postdoctoral training at renowned institutions such as The Scripps Research Institute and Stanford University, underpins her expertise in this interdisciplinary field. Since joining UC Riverside in 2023, she has committed to mentoring the next generation of scientists navigating the converging realms of aging and immune research.

The 2025 Junior Faculty Grant from AFAR not only supports Zhang’s research financially but also signifies recognition from a leading organization dedicated to pioneering biomedical research on aging. AFAR’s mission to catalyze scientific advances and translate them into practical interventions aligns seamlessly with Zhang’s visionary goals.

In sum, Huimin Zhang’s trailblazing research into the role of HELIOS in T cell aging opens a promising frontier in gerontology and immunology. By decoding and potentially reversing the epigenetic alterations that undermine immune function, her work aspires to transform the science of aging, making it a cornerstone in the development of advanced therapies that enhance longevity and quality of life. The scientific community eagerly anticipates the unfolding breakthroughs from her lab, which could redefine how we perceive and treat the aging immune system.

Subject of Research: Epigenetic regulation of T cell aging; role of HELIOS in immune function and T follicular helper cell differentiation
Article Title: Exploring HELIOS: Reprogramming Immune Aging to Enhance Vaccine Efficacy in the Elderly
News Publication Date: 2024
Web References:

• American Federation for Aging Research (AFAR): https://www.afar.org/
• UC Riverside Molecular, Cell and Systems Biology Profile: https://mcsb.ucr.edu/
• Huimin Zhang Lab: https://zlabimmunol.bio/
  Image Credits: Zhang lab, UC Riverside
  Keywords: HELIOS, T cell aging, epigenetic regulation, immunosenescence, helper T cells, T follicular helper cells, aging immunity, vaccine enhancement, B cell function, molecular reprogramming, immune rejuvenation, AFAR Junior Faculty Grant

At the heart of this investigation is the follicular helper T cell subset (T_FH), characterized by markers ICOS, CD38, PD1, and CXCR5. Despite their crucial role in aiding B cells, data reveal that frequencies of activated T_FH cells remain remarkably stable seven days post-vaccination across different adult age groups. This constancy, mirrored by consistent plasma cell counts, suggests that initial antigen-specific activation and expansion remain uncompromised throughout healthy adulthood, challenging assumptions about diminishing immune responses with age.

Yet, the story deepens when examining the transcriptional profiles of central memory CD4 T cells (CD4 T_CM). Here, a decline in T_FH-related signatures, notably CXCR5 expression, becomes evident as age progresses, implying a shift in the functional programming of these cells. Correspondingly, a reduced propensity for receptor–ligand interactions between CD4 T_CM and core memory B cells surfaces, primarily driven by diminished CD40 ligand (CD40LG) expression on T cells, despite stable CD40 expression on B cells. These molecular misalignments could subtly undermine the efficacy of B cell help rendered by memory CD4 T cells in older adults.

Intriguingly, when subjected to in vitro T cell receptor (TCR) activation, memory CD4 T cells across all ages upregulate CD40LG comparably, except for a decline noted in the more differentiated CD27-negative effector memory CD4 T cells (T_EM) of older individuals. This suggests that the fundamental machinery for B cell assistance within central memory T cells remains relatively resilient until advanced age, delineating a nuanced timeline of immune remodeling.

Focusing on the cytokine milieu and T helper subsets, the immune aging narrative gains another layer. Contrary to expectations, circulating levels of T helper cytokines do not significantly rise with age. Nevertheless, a pronounced skewing towards a T helper 2 (T_H2)-like state unfolds in CD4 T_CM cells of older adults, a trend absent for T helper 1 (T_H1) or T helper 17 (T_H17) profiles. This shift persists longitudinally and intensifies with advancing years, signaling an intrinsic reprogramming of memory T cell phenotypes rather than a transient inflammatory fluctuation.

Multi-omic approaches integrating single-cell RNA sequencing, epitope profiling, and chromatin accessibility analyses unravel the epigenetic and transcriptional underpinnings of this age-associated skewing. Pseudotime ordering reveals enhanced accessibility of motifs linked to GATA3, a master regulator directing T_H2 differentiation, across memory CD4 T cell subsets, including those expressing CXCR5. Concurrent upregulation of other transcription factors allied with T_H2 lineage specification—STAT6, STAT5A, and IRF4—further consolidates this theme, while T_H1-associated TBX21 activity remains static with age. Such transcriptional remodeling extends beyond CD4 T cells, implicating memory CD8 T cells in this sweeping T_H2-biased reconfiguration, suggesting a systemic shift within the adaptive immune compartment.

Corroborating this epigenetic landscape, chromatin accessibility profiling of the IL4 gene locus unveils heightened openness in older adults’ CD4 T_CM cells, setting the stage for amplified interleukin-4 (IL-4) expression. Indeed, cultured T cells from older donors secrete significantly increased IL-4 upon TCR engagement, reinforcing the functional manifestation of this T_H2-skewed state. Although not as pronounced, CD8 memory T cells similarly trend toward co-expression of IFNγ and IL-4 post-stimulation, associating modestly with elevated IgG3 titers against influenza antigens, suggesting broader implications for humoral immunity.

Adding an additional dimension, spontaneous IL-4 production without exogenous stimulation surges in multiple memory T cell subsets of older adults, aligning with trajectory analyses predicting a predisposed T_H2-like transcriptional bias. This basal cytokine secretion might underlie chronic immune modulation influencing B cell activity and antibody output, potentially explaining age-related shifts in vaccine responses and infection susceptibility.

Strikingly, the frequency of spontaneous IFNγ-negative, IL-4-positive CD4 T_CM cells correlates robustly with both the transcriptional memory activation marker (RAM) status and induced IL-4 secretion levels. This intimate link between cellular phenotype and cytokine output bridges molecular reprogramming with functional immune outcomes. Further, IL-4 levels post-vaccination positively associate with IgG2 subclass concentrations specific to the influenza B/Phuket strain, underscoring the nuanced interplay between T cell state, cytokine environment, and antibody quality in aging humans.

Collectively, these findings portray a progressive, transcriptionally-driven shift of memory T cells towards a T_H2-like state as a hallmark of immune aging. Such reprogramming seemingly disturbs the finely tuned crosstalk between T and B cells, altering class-switch recombination and diminishing antibody functionality with repeated antigen exposures. This evolving landscape challenges entrenched views of immune senescence solely as a decline in cell numbers or gross functionality, highlighting instead complex qualitative changes with profound immunological consequences.

Mechanistically, the persistence of T_FH cell frequencies alongside reduced T_FH signature expression and impaired CD40LG-mediated interactions suggests a decoupling of surface phenotype from transcriptional competence in aged T cells. This disparity may contribute to the observed defects in humoral immunity seen in older populations, offering new avenues for targeted interventions to bolster vaccine efficacy and immune resilience.

Moreover, the broad T_H2 skewing observed extends across memory populations of both CD4 and CD8 compartments, raising intriguing questions about the systemic drivers underpinning this shift. Whether environmental factors, chronic antigenic stimulation, or intrinsic epigenetic drift predominantly orchestrate these changes remains an alluring focus for future research.

The translational implications of this study are significant. Enhancing our capacity to modulate T_H2-biased immune responses or restore balanced T helper states could rejuvenate adaptive immunity in the elderly, improving outcomes in vaccination and infection control. Exploring agents that recalibrate transcription factor activity or chromatin accessibility might emerge as innovative strategies to reverse or mitigate immune aging.

In summary, this comprehensive multi-omic profiling unearths a previously underappreciated dimension of immune aging: the coordinated accumulation of altered T_H2-like states in memory T cells. By linking transcriptional reprogramming with functional immune shifts, the study not only enriches the conceptual framework of immunosenescence but also lays a foundation for novel therapeutic approaches aimed at sustaining immune vitality throughout aging.

Subject of Research: Age-related immune dynamics and transcriptional reprogramming in memory T cells affecting B cell function and antibody class switching in healthy adults.

Article Title: Multi-omic profiling reveals age-related immune dynamics in healthy adults

Article References:
Gong, Q., Sharma, M., Glass, M.C. et al. Multi-omic profiling reveals age-related immune dynamics in healthy adults. Nature (2025). https://doi.org/10.1038/s41586-025-09686-5

Image Credits: AI Generated